Literature DB >> 31704827

Expression, Function, and Prognostic Value of MAGE-D4 Protein in Esophageal Squamous Cell Carcinoma.

Yasuo Uno1, Mitsuro Kanda2, Yusuke Sato3, Dai Shimizu1, Shinichi Umeda1, Norifumi Hattori1, Masamichi Hayashi1, Chie Tanaka1, Daisuke Kobayashi1, Suguru Yamada1, Goro Nakayama1, Satoru Motoyama3, Masahiko Koike1, Yasuhiro Kodera1.   

Abstract

BACKGROUND/AIM: We previously reported that expression of melanoma-associated antigen (MAGE)-D4 mRNA was a prognostic factor for esophageal squamous cell carcinoma (ESCC). The aim of this study was to validate the expression of MAGE-D4 in two additional patient cohorts, and to investigate its biological functions.
MATERIALS AND METHODS: The role of MAGE-D4 in cell proliferation, adhesion, and migration was determined by gene knockdown experiments in the KYSE590 cell line. MAGE-D4 protein expression was analyzed in ESCC tissues by immunohistochemistry. A second validation cohort consisted of an ESCC mRNA dataset from The Cancer Genome Atlas.
RESULTS: Knockdown of MAGE-D4 significantly decreased cell proliferation and migration. Expression of MAGE-D4 protein was significantly associated with disease-free survival. In the second validation cohort, high MAGE-D4 mRNA expression was associated with significantly shorter overall survival and disease-free survival.
CONCLUSION: MAGE-D4 plays an important role in the malignant behavior of ESCC. MAGE-D4 was validated as a prognostic indicator in two independent ESCC patient cohorts. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Esophageal cancer; MAGE-D4; biomarker

Mesh:

Substances:

Year:  2019        PMID: 31704827     DOI: 10.21873/anticanres.13807

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  A novel circ_0000654/miR-375/E2F3 ceRNA network in esophageal squamous cell carcinoma.

Authors:  Chunyu Luo; Xiaowei Zhao; Yuan Wang; Yanqiu Li; Tuo Wang; Shumin Li
Journal:  Thorac Cancer       Date:  2022-07-05       Impact factor: 3.223

2.  Combined treatment with epigenetic agents enhances anti-tumor activity of MAGE-D4 peptide-specific T cells by upregulating the MAGE-D4 expression in glioma.

Authors:  Shui-Qing Bi; Qing-Mei Zhang; Xia Zeng; Chang Liu; Wei-Xia Nong; Huan Xie; Feng Li; Li-Na Lin; Bin Luo; Ying-Ying Ge; Xiao-Xun Xie
Journal:  Front Oncol       Date:  2022-08-03       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.